Our take: Better players demand clubs that perform precisely to their shotmaking specifications. They want irons that are controllable, predictable and that generate the trajectories they need to dial ...

Six years after Miura introduced the MB-001 — its last muscle-back iron — the equipment manufacturer is bringing a new MB-101 blade to market. Hoping to make noticeable improvements to the traditional ...

Mustang Bio Inc (NASDAQ:MBIO) stock soared over 78% following the U.S. Food and Drug Administration’s orphan drug designation for its MB-101 therapy targeting recurrent diffuse and anaplastic ...

Mustang Bio Inc (NASDAQ:MBIO) shares are trading sharply higher Monday afternoon. The company earlier saw a positive development as the FDA granted Orphan Drug Designation to its cell therapy ...